The prevalence and causes of visual loss among HIV-infected individuals in uganda

Journal of Acquired Immune Deficiency Syndromes

Volumn 53, Issue 1, 2010, Pages 95-101

  Otiti Sengeri, Juliet ^a   Colebunders, Robert ^b,c   Kempen, John H ^d   Ronald, Allan ^f,g   Sande, Merle ^e   Katabira, Elly ^a  

^a MULAGO HOSPITAL   (Uganda)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^f Infectious Diseases Institute   (Uganda)

^g UNIVERSITY OF MANITOBA   (Canada)

Author keywords

HIV; Ocular diseases; Uganda; Visual loss

Indexed keywords

ADULT; ARTICLE; CATARACT; CORNEA INJURY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; FEMALE; GLAUCOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE DISEASE; PREVALENCE; PRIORITY JOURNAL; REFRACTION ERROR; RETINA MACULOPATHY; SQUAMOUS CELL CARCINOMA; UGANDA; UVEITIS; VISION TEST; VISUAL ACUITY; VISUAL IMPAIRMENT; AGE DISTRIBUTION; COMORBIDITY; EPIDEMIOLOGY; EYE DISEASES; HIV INFECTIONS; MIDDLE AGED; RURAL POPULATION; STATISTICS AND NUMERICAL DATA; URBAN POPULATION; VISION DISORDERS;

ADULT; AGE DISTRIBUTION; CAUSALITY; COMORBIDITY; EYE DISEASES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RURAL POPULATION; UGANDA; URBAN POPULATION; VISION DISORDERS; VISUAL ACUITY;

EID: 74049156872     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181c313f0     Document Type: Article

References (41)

1. Wolfgang H, Misinguzi J, Kirungi W, et al. The estimated burden of HIV/ AIDS in Uganda 2005-2010. AIDS 2008, 22, 503-510.
2. Jabs DA. Ocular manifestations of HIV infection. Trans Am Opthalmol Soc. 1995;93:623-683.
3. Hoolbrook JT, Jabs DA, Weinberg DV, et al. Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before the widespread availability of highly active antiretroviral therapy. Arch Ophthalmol. 2003;121:99-107.
4. Ng WT, Franzco PV. Ocular association of HIV infection in the era of highly active antiretroviral therapy and the global perspective. Clin Experiment Ophthalmol. 2005;33:317-329.
5. Musinguzi B. Uganda edges closer to AIDS treatment for all. Bull World Health Organ. 2008;86:417-496.
6. Schuman JS, Orellana J, Friedman AH, et al. Acquired immunodeficiency syndrome (AIDS). Surv Ophthalmol. 1987;31:384.
7. Lewallen S, Coutright P. HIV and AIDS and the eye in developing countries. Arch Ophthalmol. 1997;115:1291-1295.
8. Kestelyn PG, Cunningham ET. HIV/AIDS and blindness. Public Health reviews. Bull World Health Organ. 2001;79:208-213.
9. World Health Organization, UNAIDS and UNICEF. Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Service. Progress Report, April 2007. Geneva, Switzerland.
10. Balo KP, Amoussou YP, Bechetoille A, et al. [Cytomegalovirus retinitis and ocular complications in AIDS patients in Togo]. J Fr Ophthalmol. 1999;22:1042-1046
11. Cunningham ET Jr Belfort R Jr. HIV/AIDS and the Eye: AGlobal Perspective. San Francisco CA: American Academy of Ophthalmology, 2002.
12. Jennifer ET, Douglas J, John HK, et al. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the Era of Highly active antiretroviral therapy. Ophthalmology. 2006;113:1441-1445.
13. Kestelyn P. The epidemiology of CMV retinitis in Africa. Ocul Immunol Inflamm. 1999;7:173-177.
14. Whitecup SM. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. JAMA. 2000;283:653-657.
15. Kempen JH, Min YI, Freeman WR, et al. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology. 2006;113:684-692.
16. Shelburne SA, Visnegarwala F, Darcourt J, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005;19:399-406.
17. Rex JR, Larsen RA, Dismukes WE, et al. Catastrophic visual loss due to Cryptococcus neoformans meningitis. Medicine. 1993;72:207-224.
18. Moraes HV. Ocular manifestations of HIV/AIDS. Curr Opin Ophthalmol. 2002;13:397-403.
19. Goldberg DE, Smithen LM, Angelilli A, et al. HIV associated retinopathy in the HAART era. Retina. 2005;25:633-649.
20. Kestelyn P, Taelman H, Bogaerts J, et al. Ophthalmic manifestations of infections with Cryptococcus neoformans in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1993;116:721-727.
21. Goyal JL, De Sarmi, Singh NP, et al. Evaluation of visual functions in patients on ethambutol therapy for tuberculosis: a prospective study. J Commun Dis. 2003;35:230-243.
22. Kestelyn P, Lewallen S. Ocular problems with HIV infection and AIDS in Africa. Community Eye Health. 1995;8:20-23.
23. Ronday MJ, Stilma JS, Barbe RF, et al. Aetiology of uveitis in Sierra Leone, west Africa. Br J Ophthalmol. 1996;80:956-961.
24. Jabs DA. Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc. 1995;93:393-402.
25. Rogers CA, Harris JR. Ocular toxoplasmosis in HIV infection. Int J STD AIDS. 1996;7:1580-1585.
26. Matos KT, Santos MC, Muccioli C. Ocular manifestations in HIV infected patients attending the department of ophthalmology of Universidade Federal de Sao Paulo. Rev Assoc Med Bras. 1999;45:323-326.
27. Umeh RE. Herpes zoster ophthalmicus and HIV infection in Nigeria. Int J STD AIDS. 1998;9:476-479.
28. Liesegang TJ. Herpes zoster viral infection. Curr Opin Ophthalmol. 2004; 15:531-536.
29. Tran TH, Cassoux N, Bodaghi B, et al. Syphilitic uveitis in patients infected with human immunodeficiency virus. Graefes Arch Clin Exp Ophthalmol. 2005;243:863-869.
30. Swai RO, Somi GGR, Matee MI, et al. Surveillance of HIV and syphilis infections among antenatal clinic attendees in Tanzania-2003/2004. BMC Public Health. 2006;6:91.
31. Dorris JP, Saha K, Jones NP, et al. Ocular syphilis: the new epidemic. Eye. 2006;20:703-705.
32. Chao JR, Khurana RN, Fawzi AA. Syphilis: reemergence of an old adversary. Ophthalmology. 2006;113:2074-2079.
33. Engstrom RE Jr, Holland GN, Margolis TP, et al. The progressive outer retinal necrosis syndrome. Avariant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology. 1994;101:1488-1502.
34. Blumenkranz MS, Culbertson WW, Clarkson JG, et al. Treatment of the acute retinal necrosis syndrome with intravenous acyclovir. Ophthalmology. 1986;93:296-300.
35. Gaynes BI. "Star" suture opacities of the crystalline lens: an illustrative report in AIDS patients. Med Sci Monit. 2005;11:13-19.
36. Iwakura Y, Shioda T, Tosu M, et al. The induction of cataracts by HIV-1 in transgenic mice. AIDS. 1992;6:1069-1075.
37. Taylor HR, West SK, Rosenthal FS, et al. Effect of ultraviolet radiation on cataract formation. N Engl J Med. 1988;319:1429-1433.
38. Cunninghan ET, Levinson RD, Jampol LM, et al. Ischemic maculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 2001;132:727-733.
39. Mbulaiteye SM, Reeves BC, Mulwanyi F, et al. Incidence of visual loss in rural south west Uganda. Br J Ophthalmol. 2003;87:829-833.
40. Westcott MC, Ward M, Mitchell SM. Failure of accommodation in patients with HIV infection. Eye. 2001;15:474-478.
41. Otiti-Sengeri J, Meenken C, Van den Horn GJ, et al. Ocular immune reconstitution inflammatory syndromes. Curr Opin HIV AIDS. 2008; 3:432-437.